Peptide Reports

5-Amino-1MQ Peptide Report

Peptide Report

5-Amino-1MQ Peptide Report

Catalog report for 5-Amino-1MQ, generated from Peptide Stacks product data and linked to the matching PeptideReports protocol page when available.

All peptide reportsProtocol library
Current Price$49.99 – $99.00 CAD
Protocol5-Amino-1MQ protocol
Catalog SourceBuy Product

Available Options

  • 5 MG
  • 50 MG

Common Uses

People commonly discuss 5-Amino-1MQ for body-composition goals, metabolic support, appetite discipline, and energy-focused routines, especially when they are trying to improve how consistently they manage diet and training.

How It Works

5-Amino-1MQ is discussed as an NNMT inhibitor. By reducing nicotinamide N-methyltransferase activity, it is studied for its effect on nicotinamide metabolism, NAD+ availability, methylation balance, and downstream energy-handling pathways in fat and muscle tissue.

Storage

Powder form: In lyophilized powder form, 5-Amino-1MQ is generally kept sealed, dry, protected from direct light, and refrigerated unless the product label or certificate of analysis gives different handling instructions. Avoid leaving vials in hot rooms, vehicles, direct sunlight, or other temperature swings, because moisture, heat, and light are the main storage conditions people try to control before reconstitution.

Reconstituted: After reconstitution, 5-Amino-1MQ should generally be treated as more sensitive: keep it refrigerated, minimize unnecessary handling, avoid shaking, and use clean handling practices each time the vial is accessed. Follow the product label, protocol page, and any pharmacy or lab guidance for beyond-use timing; if the solution changes color, becomes cloudy, develops particles, or the vial integrity is questionable, it should not be used.

Protocol

The full 5-Amino-1MQ protocol is included below. The standalone protocol page remains available if you want to open it separately.

Open Standalone Protocol

Scope

Preparation examples, syringe conversion, community-reported patterns and important limitations.

Available strengths: 5 MG and 50 MG

Preparation Examples

These are calculation examples only. The concentration assumptions below are explicit so syringe units are never separated from vial strength and diluent volume.

Setup Diluent Concentration Unit conversion
5 MG vial – 2 mL example Add 2 mL bacteriostatic water 2.5 mg/mL Each U-100 unit = 25 mcg
50 MG vial – 2 mL example Add 2 mL bacteriostatic water 25 mg/mL Each U-100 unit = 250 mcg

Syringe Conversion

Reported amount 5 MG setup 50 MG setup
5 mg 200 units 20 units
10 mg 400 units 40 units
25 mg 1000 units 100 units
50 mg 2000 units 200 units

Always recalculate from the actual vial strength and diluent volume. A U-100 unit is 0.01 mL; it is not a dose by itself.

Community-Reported Patterns

Recurring report Frequency seen Context in reports
25 mg Once daily Lower-start discussions
50 mg Once daily Most recurring amount reviewed
50-100 mg Daily in divided reports Higher experimental use

Observations

  • Community discussions most often centered on body-composition, appetite and metabolic-energy goals.
  • The amount, frequency, route and cycle length varied substantially between reports.
  • Reported outcomes were commonly confounded by diet, training, other products or existing treatment.

Caveats

  • 5-Amino-1MQ is an experimental NNMT inhibitor with no established human dosing or long-term safety standard.
  • Community reports are uncontrolled anecdotes and do not establish an appropriate dose, safety, product identity, purity or efficacy.

Sources

  1. Community search: 5-Amino-1MQ
  2. PubMed literature search: 5-Amino-1MQ